De Novo Foodlabs (De Novo), a food technology company focused on creating rare protein-based functional ingredients, has announced fresh capital, bringing its total investment to $4 million led by sustainable protein venture capital firm Joyful Ventures, highlights the immense potential of De Novo’s state-of-the-art, animal-free protein solutions to reshape the health and wellness landscape and to fast-track the commercialization of its revolutionary precision fermented lactoferrin product, NanoFerrin™.
Read also – [Funding News] Accenture Invests in Earli Inc. to Advance Technologies for Early Cancer Detection
This latest funding round follows initial investments from Sustainable Food Ventures, Siddhi Capital, Pascual Innoventures, UM6P Ventures, Cult Food Science, and Prithvi Capital, bringing De Novo’s total funding to $4 million since its inception in 2021.
Read also – Funding Wrap of the Week | American Startups Funding Roundup | August 12 – August 16
Lactoferrin is a protein found in cow’s colostrum (or first milk) that delivers powerful health benefits. It has antimicrobial and anti-inflammatory properties that benefit gut health. It also boosts the immune system and delivers cognitive and anti-aging benefits. All of which makes lactoferrin a truly remarkable, and crucial, nutrient for those looking to live a long and healthy life.
“The lactoferrin market has long been hindered by high prices and inconsistent supply,” said Jean Louwrens, CEO and Co-Founder of De Novo Foodlabs. “Our team of leading scientists and engineers has dedicated themselves to overcoming these challenges through precision fermentation technology, and we are thrilled to have achieved a breakthrough. NanoFerrin is not only more affordable and eco-friendly; importantly, it also provides a reliable supply source compared to traditional bovine lactoferrin products. We are excited to collaborate with our investors to elevate De Novo to new heights.”
“De Novo Foodlabs exemplifies the innovation and sustainability we champion at Joyful Ventures,” stated Milo Runkle, General Partner at Joyful Ventures, and Co-Founder of the Good Food Institute. “Their advancements in precision fermentation technology and dedication to creating impactful alternatives to high-value animal-derived ingredients pave the way for scalable and profitable industry solutions.” As part of the investment, Mr. Runkle will join De Novo’s Board of Directors.
Through the scientific rigor of De Novo Foodlabs technology, it has developed a revolutionary, nature-identical protein that delivers all of the extraordinary health and longevity benefits of lactoferrin. But unlike lactoferrin, NanoFerrin production is consistent, scalable, and cost-effective – making it good for business and the environment.
About De Novo Foodlabs
Founded in 2021, De Novo Foodlabs is a pioneering biotech start-up revolutionizing the field of nutrition. Leveraging the power of microbial fermentation, the company creates innovative products that promote better health for both people and the planet.
